NANOBIOTIX SA - ADR (NBTX) Stock Overview
USA - NASDAQ:NBTX - US63009J1079 - ADR
NBTX Key Statistics, Chart & Performance
The current stock price of NBTX is 9.6987 USD. In the past month the price increased by 18.28%. In the past year, price increased by 95.93%.
NBTX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.62 | 385.71B | ||
| AMGN | AMGEN INC | 12.67 | 148.80B | ||
| GILD | GILEAD SCIENCES INC | 14.8 | 142.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.29 | 101.15B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.07B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.27 | 59.35B | ||
| ARGX | ARGENX SE - ADR | 81.59 | 46.29B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.67 | 38.56B | ||
| INSM | INSMED INC | N/A | 30.85B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.26B | ||
| NTRA | NATERA INC | N/A | 23.13B | ||
| BIIB | BIOGEN INC | 9.05 | 21.24B |
Related stock screener links
About NBTX
Company Profile
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 108 full-time employees. The company went IPO on 2012-10-29. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The company develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Company Info
NANOBIOTIX SA - ADR
60 rue de Wattignies
Paris ILE-DE-FRANCE 75012 FR
CEO: Dr. Laurent Levy
Employees: 108
Phone: 33140260470
NANOBIOTIX SA - ADR / NBTX FAQ
What is the stock price of NANOBIOTIX SA - ADR today?
The current stock price of NBTX is 9.6987 USD. The price decreased by -2.53% in the last trading session.
What is the ticker symbol for NANOBIOTIX SA - ADR stock?
The exchange symbol of NANOBIOTIX SA - ADR is NBTX and it is listed on the Nasdaq exchange.
On which exchange is NBTX stock listed?
NBTX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NANOBIOTIX SA - ADR stock?
12 analysts have analysed NBTX and the average price target is 13.56 USD. This implies a price increase of 39.82% is expected in the next year compared to the current price of 9.6987. Check the NANOBIOTIX SA - ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NANOBIOTIX SA - ADR worth?
NANOBIOTIX SA - ADR (NBTX) has a market capitalization of 464.77M USD. This makes NBTX a Small Cap stock.
How many employees does NANOBIOTIX SA - ADR have?
NANOBIOTIX SA - ADR (NBTX) currently has 108 employees.
What are the support and resistance levels for NANOBIOTIX SA - ADR (NBTX) stock?
NANOBIOTIX SA - ADR (NBTX) has a support level at 8.37 and a resistance level at 10.1. Check the full technical report for a detailed analysis of NBTX support and resistance levels.
Is NANOBIOTIX SA - ADR (NBTX) expected to grow?
The Revenue of NANOBIOTIX SA - ADR (NBTX) is expected to grow by 5.81% in the next year. Check the estimates tab for more information on the NBTX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NANOBIOTIX SA - ADR (NBTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NBTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NBTX, evaluating the profitability, health, valuation and growth aspects
- NANOBIOTIX SA - ADR (NBTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NANOBIOTIX SA - ADR (NBTX) Sales and EPS estimates to see what analysts future expectations are.
- NANOBIOTIX SA - ADR (NBTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NANOBIOTIX SA - ADR (NBTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- NANOBIOTIX SA - ADR (NBTX) Stock Chart to make your own analysis
- NANOBIOTIX SA - ADR (NBTX) Latest news and press-releases to stay up to date.
Does NANOBIOTIX SA - ADR (NBTX) stock pay dividends?
NBTX does not pay a dividend.
When does NANOBIOTIX SA - ADR (NBTX) report earnings?
NANOBIOTIX SA - ADR (NBTX) will report earnings on 2025-09-16.
What is the Price/Earnings (PE) ratio of NANOBIOTIX SA - ADR (NBTX)?
NANOBIOTIX SA - ADR (NBTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.67).
What is the Short Interest ratio of NANOBIOTIX SA - ADR (NBTX) stock?
The outstanding short interest for NANOBIOTIX SA - ADR (NBTX) is 0.05% of its float. Check the ownership tab for more information on the NBTX short interest.
NBTX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to NBTX. When comparing the yearly performance of all stocks, NBTX is one of the better performing stocks in the market, outperforming 95.56% of all stocks.
NBTX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NBTX. Both the profitability and financial health of NBTX have multiple concerns.
NBTX Financial Highlights
Over the last trailing twelve months NBTX reported a non-GAAP Earnings per Share(EPS) of -1.67. The EPS decreased by -33.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -101.06% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NBTX Forecast & Estimates
12 analysts have analysed NBTX and the average price target is 13.56 USD. This implies a price increase of 39.82% is expected in the next year compared to the current price of 9.6987.
For the next year, analysts expect an EPS growth of 41.35% and a revenue growth 5.81% for NBTX